InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: jimtash post# 18952

Thursday, 12/05/2013 9:26:21 AM

Thursday, December 05, 2013 9:26:21 AM

Post# of 30046
yes, exactly, that is why he personally got up on stage and pitched it.

In Summer 2012 he thought he had an investor lined up -- they called it "a Midwestern investor" -- but that investor backed out. We have to assume he kept looking for funding but in April 2013 he went on stage at AZBio and delivered his sales pitch.

Think about it. A sales pitch at AZBio? Cheapens the event, IMO. Gartner is on the BOD of AZBio and one of their success stories -- otherwise I don't think they would have let him do it.

The class action lawsuit named Radient and MacLellan, and insurance covered it. That did not hold up anything, IMO. But we will know, won't we, since that is over as of yesterday.

I seriously doubt that Gartner got funding from his sales pitch at AZBio. That audience was not there to invest. And Gartner's Fundable attempt was jut embarrassing, IMO -- he got two people to pledge $100 each and he quit long before the end of the contest. Why did he even try? If you think it was because he wanted "exposure," then why did he quit? I think he was that desperate for $20,000.

You ask "why leave the GCDx website up?" but I ask "for $5.99 per month, why take it down?" He's not monitoring that site or updating it -- just paying the $5.99 monthly fee to GoDaddy. Have you tried contacting GCDx from the contact info on that website? I have -- no answer.

It's easy and cheap to put up a website today. Nobody audits them. If you want to pay $5.99 per month for the site and about $20 for a domain name, YOU can have a website that pretends to sell DR-70. Remember Guar Diagno? Remember the fake doctor testimonials on the Guar Diagno site? The white vans?



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.